Indication

Delayed puberty

Delayed puberty is an endocrine and developmental condition characterized by the absence of expected secondary sexual characteristics at an age greater than two to 2.5 standard deviations above the population mean. Read more about Delayed puberty

17 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Delayed puberty therapies.

Showing 1–9 of 17 drugs

Filter & compare in the drug finder →Opens the drug finder with Delayed puberty preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Delayed puberty.

Delayed puberty is an endocrine and developmental condition characterized by the absence of expected secondary sexual characteristics at an age greater than two to 2.5 standard deviations above the population mean.

It affects adolescents and is clinically defined by the lack of breast development in girls by age 13 or the absence of testicular enlargement (testicular volume less than 4 mL) in boys by age 14, as well as an arrest in pubertal progression.

Pathophysiologically, the disorder stems from delayed or impaired activation of the hypothalamic-pituitary-gonadal axis, which may result from self-limited constitutional delay of growth and puberty, functional hypogonadotropic hypogonadism due to systemic illness, permanent central gonadotropin deficiency, or primary gonadal failure.

Personalize your experience

Follow Delayed puberty and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it